Highlights
ORCRP013215
A collection of news and information related to Roche Holding AG published by this site and its partners.
Displaying items 1-12 of 34
» View courant.com items only
1
2
3
•
Next >
-
Wall Street posts first weekly loss since mid-April on Fed angst
ReutersNEW YORK (Reuters) - The S&P 500 declined for a third day on Friday, with the three major stock indexes posting their first negative week since mid-April on lingering concern that the central bank may scale back its stimulus measures to support the...Tags: Warren Buffett, Computer Sciences Corporation, Time Warner Telecom Inc., Hybrid Vehicles, Real Estate Sales
-
Immune system cancer drugs tipped to be a $35 bln market
Reuters* Potential sales of $35 bln a year over next 10 years - Citigroup * Immunotherapy may be used in up to 60 percent of cancers * Bristol-Myers Squibb and Roche both upgraded to "buy" By Ben Hirschler LONDON, May 22 (Reuters) - A new wave of medicines...Tags: Science and Technology, Amgen Inc., Health Treatments, Novartis AG, GlaxoSmithKline PLC
-
Immune system cancer drugs tipped to be a $35 billion market
ReutersLONDON (Reuters) - A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. That bullish sales forecast by analysts at U.S. bank...Tags: Science and Technology, Health Treatments, Amgen Inc., Novartis AG, GlaxoSmithKline PLC
-
Inmunoterapia contra el cáncer podrÃa ser un mercado de 35.000 mln dlrs anuales
ReutersPor Ben Hirschler LONDRES, 22 may (Reuters) - Una nueva ola de medicinas que emplea el poder del sistema inmunológico para luchar contra el cáncer podrÃa convertirse en el mayor grupo de medicamentos de la historia, con ventas potenciales de 35.000...Tags: Amgen Inc., Bristol Myers Squibb Company, Novartis AG, Merck & Company Incorporated, GlaxoSmithKline PLC
-
Market Chatter-Corporate finance press digest
ReutersMay 22 (Reuters) - The following corporate finance-related stories were reported by media on Wednesday: * Australia's Westfield Group is in talks to sell seven U.S. shopping malls to private real estate investment company Starwood Capital Group for more...Tags: Manufacturing and Engineering, Finance, Australia, Automotive Equipment, China
-
Roche, Sigma teamed up for failed Life Technologies bid -sources
ReutersBy Soyoung Kim and Greg Roumeliotis NEW YORK, May 21 (Reuters) - Roche Holding AG teamed up with Sigma-Aldrich Corp to make an unsuccessful bid for Life Technologies Corp earlier this year, people familiar with the matter said. Life Tech, the genetic...Tags: Illumina, Inc., Medical Research, Sigma-Aldrich Corporation
-
Pfizer halts study of lymphoma drug unlikely to help survival
Reuters(Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive non-Hodgkin lymphoma after independent monitors found it was not...Tags: Science and Technology, Food and Drug Administration, Health Treatments, Biotechnology, Hodgkin's Lymphoma
-
New cancer tools allow patients to reconsider chemo
ReutersLOS ANGELES (Reuters) - After decades of using one-size-fits-all therapies to combat cancer, doctors are using new tools to help decide when their patients can skip chemotherapy or other harsh treatments. An approach to oncology that has been in place...Tags: Science and Technology, Health Treatments, Prostate Cancer, Heart Problems, Lymphoma
-
CORRECTED-Data show new Roche leukemia drug may improve on Rituxan
Reuters(Corrects paragraph 12 to show Biogen has stake in new drug) By Bill Berkrot May 15 (Reuters) - An experimental leukemia treatment that Roche Holding AG hopes will improve upon its best-selling cancer drug Rituxan delayed disease progression twice as...Tags: Heart Disease, Science and Technology, Health Treatments, Trials, Biogen Idec Incorporated
-
RPT-Market Chatter-Corporate finance press digest
ReutersMay 16 (Reuters) - The following corporate finance-related stories were reported by media on Thursday: * Dish Network Corp has lined up four banks to finance its $25.5 billion bid for Sprint Nextel Corp, escalating the bidding war against Japanese...Tags: JPMorgan Chase & Co., Bain Capital, LLC, Cubist Pharmaceuticals Incorporated, Drugs and Medicines, Economy, Business and Finance
-
EXCLUSIVE-Roche exploring sale of diabetes device unit
ReutersBy Jessica Toonkel NEW YORK, May 15 (Reuters) - Swiss drugmaker Roche Holding AG is exploring a sale of its blood glucose meters business, three people familiar with the matter told Reuters on Wednesday, as the industry grapples with increased...Tags: Medtronic Incorporated, Government Health Care, Bayer AG, Diabetes, Germany
-
Bill would regulate 'biosimilar' drugs
SACRAMENTO — Two of the nation's largest biotech companies — Amgen Inc. of Thousand Oaks and Genentech Inc. of South San Francisco — are fighting in Sacramento to keep a tight grip on some of their most lucrative drugs. At stake is a...
Tags: Pharmaceuticals, Exports, Amgen Inc., Imports, Food and Drug Administration
May 24, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 22, 2013
|Story| Reuters
May 21, 2013
|Story| Reuters
May 21, 2013
|Story| Reuters
May 20, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 12, 2013
|Story| Los Angeles Times
Original site for Roche Holding AG topic gallery.
